Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Nidan Labs Health
Join Channel
Consolidated Standalone

Nidan Labs. & Health

₹34.5 0 | 0%

WEBSITE BSE:0 NSE : 17 May, 00:00

Market Cap ₹48 Cr.

Stock P/E

P/B 0.7

Current Price ₹34.5

Book Value ₹ 50

Face Value 10

52W High ₹57.7

Dividend Yield 0%

52W Low ₹ 27

Edit Ratio

Nidan Labs. & Health Research see more...

Overview Inc. Year: 2000Industry: Hospital & Healthcare Services

Nidan Labs. & Health Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Nidan Labs. & Health Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Nidan Labs. & Health Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 20 21 20 30 24
Other Income 0 0 1 0 3
Total Income 20 21 21 30 28
Total Expenditure 12 14 11 20 17
Operating Profit 8 8 10 10 10
Interest 5 4 3 3 2
Depreciation 3 3 3 3 3
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 0 1 3 5 5
Provision for Tax 0 0 1 2 1
Profit After Tax 0 1 2 3 4
Adjustments 0 0 0 0 0
Profit After Adjustments 0 1 2 3 4
Adjusted Earnings Per Share 0 0 2.3 1.9 2.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -20% 5% 0% 0%
Operating Profit CAGR 0% 8% 0% 0%
PAT CAGR 33% 59% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -18% NA% NA% NA%
ROE Average 5% 10% 8% 8%
ROCE Average 9% 11% 11% 11%

Nidan Labs. & Health Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 10 11 13 66 69
Minority's Interest 0 0 0 0 0
Borrowings 32 34 14 9 5
Other Non-Current Liabilities -0 -0 -0 -0 0
Total Current Liabilities 1 -0 26 13 10
Total Liabilities 43 45 53 88 84
Fixed Assets 23 20 20 20 21
Other Non-Current Assets 1 1 11 42 42
Total Current Assets 19 24 23 25 21
Total Assets 43 45 53 88 84

Nidan Labs. & Health Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 4 7 7 8
Cash Flow from Operating Activities 9 5 4 8 14
Cash Flow from Investing Activities 1 -0 -3 -36 -3
Cash Flow from Financing Activities -6 -2 -1 29 -11
Net Cash Inflow / Outflow 4 3 -0 1 0
Closing Cash & Cash Equivalent 4 7 7 8 8

Nidan Labs. & Health Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0 0 2.33 1.92 2.55
CEPS(Rs) 3.49 3.94 5.54 3.81 4.78
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 0 0 13.47 47.41 49.96
Core EBITDA Margin(%) 39.1 35.67 43.61 31.74 28.04
EBIT Margin(%) 24.8 20.82 33.19 24.23 28.99
Pre Tax Margin(%) 1.11 3.34 16.21 15.24 19.83
PAT Margin (%) 1.11 3.34 11.3 8.98 14.59
Cash Profit Margin (%) 17.24 18.23 26.93 17.85 27.35
ROA(%) 0.52 1.63 4.68 3.76 4.12
ROE(%) 2.17 6.7 18.9 6.72 5.23
ROCE(%) 11.71 10.15 13.98 10.52 8.5
Receivable days 102.1 94.15 97.3 66.41 85.65
Inventory Days 1.38 1.38 1.72 1.98 4.37
Payable days 116.21 26.19 91.4 144.01 227.03
PER(x) 0 0 0 17.33 13.29
Price/Book(x) 0 0 0 0.7 0.68
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 1.88 1.72 1.99 1.93 2.04
EV/Core EBITDA(x) 4.59 4.82 4.09 5.84 4.89
Net Sales Growth(%) 0 6.71 -4.81 45.55 -18.19
EBIT Growth(%) 0 -10.42 51.76 6.23 -2.09
PAT Growth(%) 0 219.73 222.21 15.65 32.92
EPS Growth(%) 0 0 222.21 -17.63 32.92
Debt/Equity(x) 3.12 3.11 2.85 0.29 0.16
Current Ratio(x) 33.07 -142.02 0.88 1.98 2.19
Quick Ratio(x) 32.94 -141.52 0.87 1.96 2.15
Interest Cover(x) 1.05 1.19 1.95 2.7 3.16
Total Debt/Mcap(x) 0 0 0 0.42 0.23

Nidan Labs. & Health Shareholding Pattern

# Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024
Promoter 71.22 71.22 71.22 62.79 57.04
FII 0 0 0 0 0
DII 0 0 0 0 0
Public 28.78 28.78 28.78 37.21 42.96
Others 0 0 0 0 0
Total 100 100 100 100 100

Pros

  • Stock is trading at 0.7 times its book value
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Company has a low return on equity of 10% over the last 3 years.
  • Debtor days have increased from 144.01 to 227.03days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Nidan Labs. & Health News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!